Serving To Educate Primary Care Clinicians On Metabolic Issues
Home
Subscribe
Feedback
Contact Us
Evidence Based Medicine
Medical Education
Metabolic Diseases
About Us
PCMG CME
PCMG Non-CME
Resources
Needs Survey
Commentaries
Survey
NPACE Webinar What's New in CGM Post Survey
I am a(n)…
Select...
MD/DO
NP/RN
PA
Other
How many years have you been in practice?
Select...
1-5
6-10
11-15
16-20
Over 20
What is your practice setting?
Select...
Solo Practice
Group Practice
Hospital
Clinic
Academic
Other
Number of patients seen per month with Diabetes
Select...
1-10
11-20
21-30
31-40
41-50
Over 50
Please rate the following:
Degree to which your educational expectations were met
Select...
Excellent
Above Average
Average
Fair
Poor
Relevance to your practice
Select...
Excellent
Above Average
Average
Fair
Poor
Effective faculty presenter
Select...
Excellent
Above Average
Average
Fair
Poor
Overall Presentation
Select...
Excellent
Above Average
Average
Fair
Poor
Please rate the degree to which Learning Objectives were met.
Describe new and emerging technologies in CGM use, including OTC CGM devices and continuous glucose-ketone monitoring.
Select...
Completely
Mostly
Somewhat
Not at all
Interpret CGM data such as the AGP accurately to inform changes in diabetes therapy and optimize glucose control.
Select...
Completely
Mostly
Somewhat
Not at all
Initiate CGM in patients with diabetes who would benefit from enhanced glucose monitoring and better blood glucose control, including those with insulin delivery devices.
Select...
Completely
Mostly
Somewhat
Not at all
Engage members of the health care team in collaborating on diabetes management and to help patients receive CGM.
Select...
Completely
Mostly
Somewhat
Not at all
Agree or Disagree?
The presentation was fair and balanced, free of commercial bias.
Select...
YES
NO
I feel more competent as a result of the presentation.
Select...
YES
NO
The presentation was scientifically rigorous.
Select...
YES
NO
This activity will help the healthcare team improve patient outcomes in my practice setting.
Select...
Strongly Agree
Agree
Unsure
Disagree
Strongly Disagree
Will you change your practice behaviors as a result of the presentation?
Select...
Absolutely
Probably
Unsure
Unlikely
No
What will you change?
Review AGP at each visit and modify the treatment plan accordingly
Offer CGM as an option to my patients with diabetes
Prescribe CGM for patients with diabetes who would benefit from improved glucose control
Discuss OTC CGM devices with patients who would benefit
More sensitive to issues of treatment disparities
Use this knowledge to improve the skills, strategy and performance of the healthcare team
Educate my patients
Other
If Other
Because you are likely to make changes to your practice behaviors, you are eligible to qualify for T2P (Translation to Practice) Credit, an additional 2.0 Credits. Please provide your email address below and we will send you a link to a followup survey in six weeks. If you have made changes to your practice behaviors, you will receive those additional two credits.
What barriers to change do you foresee?
Cost
Insurance Coverage
Formulary
Patient Adherence
Time with Patient
Other
None
If Other
What was your level of knowledge on this subject?
Before the presentation
Select...
None
Little
Some
Considerable
Expert
After the presentation
Select...
None
Little
Some
Considerable
Expert
The HbA1c (glycated hemoglobin) is the gold standard of care and used to guide clinicians in managing diabetes. Which of the following statements is true?
Looking at an HbA1c value advises the clinician when a patient with diabetes is having low blood glucose.
The HbA1c provides enough data to determine how well a patient’s diabetes is controlled.
The HbA1c provides a 30- to 90-day retrospective average of blood glucose data. .
The HbA1c and the glucose management indicator (GMI) are interchangeable.
The risk of diabetic ketoacidosis (DKA) exists in both type 1 and type 2 diabetes. Which of the following statements is true?
The risk for DKA in type 2 diabetes is greatest at diagnosis.
The best tool available to test for ketones at home is the dual blood glucose ketone CGM.
DKA is characterized by hypoglycemia, ketosis, and anion gap metabolic acidosis.
Both urine ketone testing and blood ketone testing are available to do at home.
How confident do you feel in your answer to the previous question?
Select...
Very confident
Confident
Somewhat confident
Not confident
What would you like to learn more about on this subject?
Submit